Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893003059> ?p ?o ?g. }
- W2893003059 endingPage "545" @default.
- W2893003059 startingPage "533" @default.
- W2893003059 abstract "B-cell precursor-acute lymphoblastic leukemia modulates the bone marrow (BM) niche to become leukemia-supporting and chemo-protective by reprogramming the stromal microenvironment. New therapies targeting the interplay between leukemia and stroma can help improve disease outcome. We identified ActivinA, a TGF-β family member with a well-described role in promoting several solid malignancies, as a factor favoring leukemia that could represent a new potential target for therapy. ActivinA resulted over-expressed in the leukemic BM and its production was strongly induced in mesenchymal stromal cells after culture with leukemic cells. Moreover, MSCs isolated from BM of leukemic patients showed an intrinsic ability to secrete higher amounts of ActivinA compared to their normal counterparts. The pro-inflammatory leukemic BM microenvironment synergized with leukemic cells to induce stromal-derived ActivinA. Gene expression analysis of ActivinA-treated leukemic cells showed that this protein was able to significantly influence motility-associated pathways. Interestingly, ActivinA promoted random motility and CXCL12-driven migration of leukemic cells, even at suboptimal chemokine concentrations, characterizing the leukemic niche. Conversely, ActivinA severely impaired CXCL12-induced migration of healthy CD34+ cells. This opposite effect can be explained by the ability of ActivinA to increase intracellular calcium only in leukemic cells, boosting cytoskeleton dynamics through a higher rate of actin polymerization. Moreover, by stimulating the invasiveness of the leukemic cells, ActivinA was found to be a leukemia-promoting factor. Importantly, the ability of ActivinA to enhance BM engraftment and the metastatic potential of leukemic cells was confirmed in a xenograft mouse model of the disease. Overall, ActivinA was seen to be a key factor in conferring a migratory advantage to leukemic cells over healthy hematopoiesis within the leukemic niche." @default.
- W2893003059 created "2018-10-05" @default.
- W2893003059 creator A5001407752 @default.
- W2893003059 creator A5012186993 @default.
- W2893003059 creator A5013560979 @default.
- W2893003059 creator A5022712318 @default.
- W2893003059 creator A5036610091 @default.
- W2893003059 creator A5037625460 @default.
- W2893003059 creator A5039412423 @default.
- W2893003059 creator A5048743157 @default.
- W2893003059 creator A5051520180 @default.
- W2893003059 creator A5057678079 @default.
- W2893003059 creator A5057785491 @default.
- W2893003059 creator A5059914426 @default.
- W2893003059 creator A5063399713 @default.
- W2893003059 creator A5069266145 @default.
- W2893003059 creator A5079441146 @default.
- W2893003059 creator A5080096851 @default.
- W2893003059 creator A5083575870 @default.
- W2893003059 creator A5091256512 @default.
- W2893003059 date "2018-09-27" @default.
- W2893003059 modified "2023-10-07" @default.
- W2893003059 title "ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells" @default.
- W2893003059 cites W1262816711 @default.
- W2893003059 cites W1787568382 @default.
- W2893003059 cites W1801876107 @default.
- W2893003059 cites W1966659976 @default.
- W2893003059 cites W1975673303 @default.
- W2893003059 cites W1978738970 @default.
- W2893003059 cites W1980952112 @default.
- W2893003059 cites W1981728331 @default.
- W2893003059 cites W1986439979 @default.
- W2893003059 cites W1997686829 @default.
- W2893003059 cites W2013322454 @default.
- W2893003059 cites W2020622102 @default.
- W2893003059 cites W2036741145 @default.
- W2893003059 cites W2037111838 @default.
- W2893003059 cites W2038155245 @default.
- W2893003059 cites W2041402420 @default.
- W2893003059 cites W2048007521 @default.
- W2893003059 cites W2051646706 @default.
- W2893003059 cites W2060818768 @default.
- W2893003059 cites W2061758394 @default.
- W2893003059 cites W2067047023 @default.
- W2893003059 cites W2067347835 @default.
- W2893003059 cites W2073006092 @default.
- W2893003059 cites W2074583458 @default.
- W2893003059 cites W2079595896 @default.
- W2893003059 cites W2080719056 @default.
- W2893003059 cites W2081814366 @default.
- W2893003059 cites W2093818708 @default.
- W2893003059 cites W2095082141 @default.
- W2893003059 cites W2105435030 @default.
- W2893003059 cites W2117692326 @default.
- W2893003059 cites W2123981503 @default.
- W2893003059 cites W2140966153 @default.
- W2893003059 cites W2148631711 @default.
- W2893003059 cites W2155011516 @default.
- W2893003059 cites W2157155777 @default.
- W2893003059 cites W2159913536 @default.
- W2893003059 cites W2160888447 @default.
- W2893003059 cites W2168966020 @default.
- W2893003059 cites W2174026431 @default.
- W2893003059 cites W2186618994 @default.
- W2893003059 cites W2301430541 @default.
- W2893003059 cites W2363557629 @default.
- W2893003059 cites W2516755574 @default.
- W2893003059 cites W2532895721 @default.
- W2893003059 cites W2559963104 @default.
- W2893003059 cites W2569807751 @default.
- W2893003059 cites W2573729299 @default.
- W2893003059 cites W2594167610 @default.
- W2893003059 cites W2603616104 @default.
- W2893003059 cites W2626760894 @default.
- W2893003059 doi "https://doi.org/10.3324/haematol.2018.188664" @default.
- W2893003059 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6395324" @default.
- W2893003059 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30262563" @default.
- W2893003059 hasPublicationYear "2018" @default.
- W2893003059 type Work @default.
- W2893003059 sameAs 2893003059 @default.
- W2893003059 citedByCount "21" @default.
- W2893003059 countsByYear W28930030592019 @default.
- W2893003059 countsByYear W28930030592020 @default.
- W2893003059 countsByYear W28930030592021 @default.
- W2893003059 countsByYear W28930030592022 @default.
- W2893003059 countsByYear W28930030592023 @default.
- W2893003059 crossrefType "journal-article" @default.
- W2893003059 hasAuthorship W2893003059A5001407752 @default.
- W2893003059 hasAuthorship W2893003059A5012186993 @default.
- W2893003059 hasAuthorship W2893003059A5013560979 @default.
- W2893003059 hasAuthorship W2893003059A5022712318 @default.
- W2893003059 hasAuthorship W2893003059A5036610091 @default.
- W2893003059 hasAuthorship W2893003059A5037625460 @default.
- W2893003059 hasAuthorship W2893003059A5039412423 @default.
- W2893003059 hasAuthorship W2893003059A5048743157 @default.
- W2893003059 hasAuthorship W2893003059A5051520180 @default.
- W2893003059 hasAuthorship W2893003059A5057678079 @default.
- W2893003059 hasAuthorship W2893003059A5057785491 @default.